Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

HT-29/STAT5 Reporter (Luc) stable cell line

HT-29/STAT5 Reporter (Luc) cells are derived from the human colon cancer cell line HT-29 by stably integration of a STAT5 firefly luciferase reporter construct. HT-29 cell line has been widely used to study molecular mechanism under cancer development, including tumor growth, invasion, and metastasis, as well as identify potential therapeutic targets. HT-29/STAT5 Reporter (Luc) cells stably express firefly luciferase under the control of the STAT5 response elements, can be used for monitoring the activity of STAT5 signaling pathway.

Product Specifications

No additional specifications available.

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD8 (RIV11), CF647 conjugate, 0.1mg/mL
BNC470333-500 1x 500 µL

CD8 (RIV11), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MART-1 / Melan-A (M2-7C10), CF640R conjugate, 0.1mg/mL
BNC400009-500 1x 500 µL

MART-1 / Melan-A (M2-7C10), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MUC18 / Mucin 18 / CD146 (OJ79c), CF640R conjugate, 0.1mg/mL
BNC400676-500 1x 500 µL

MUC18 / Mucin 18 / CD146 (OJ79c), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD34 (ICO-115), CF488A conjugate, 0.1mg/mL
BNC880039-100 1x 100 µL

CD34 (ICO-115), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD46 (122.2), CF640R conjugate, 0.1mg/mL
BNC400175-500 1x 500 µL

CD46 (122.2), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Bcl-6 (Follicular Lymphoma Marker) (BCL6/1527), CF488A conjugate, 0.1mg/mL
BNC881527-100 1x 100 µL

Bcl-6 (Follicular Lymphoma Marker) (BCL6/1527), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details